×

Methods and compositions for the treatment of CNS-related conditions

  • US 20050245617A1
  • Filed: 01/31/2005
  • Published: 11/03/2005
  • Est. Priority Date: 01/29/2004
  • Status: Abandoned Application
First Claim
Patent Images

1. A pharmaceutical composition comprising:

  • (a) an NMDA receptor antagonist;

    (b) a second agent, wherein said agent is a monoamine oxidase (MAO) inhibitor or a GADPH inhibitor; and

    (c) a pharmaceutically acceptable carrier wherein said NMDA receptor antagonist, said second agent, or both are in an extended release dosage form.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×